Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure (DAPA-HF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03036124
Recruitment Status : Completed
First Posted : January 30, 2017
Last Update Posted : August 15, 2019
Sponsor:
Information provided by (Responsible Party):
AstraZeneca

Brief Summary:
The purpose of this study is to evaluate the effect of dapagliflozin on the incidence of worsening heart failure or cardiovascular death in patients with chronic heart failure with reduced ejection fraction

Condition or disease Intervention/treatment Phase
Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) Drug: Dapagliflozin Drug: Placebo Phase 3

Detailed Description:
This is an international, multicentre, parallel group, event-driven, randomized, double-blind, placebo-controlled study in patients with chronic heart failure with reduced ejection fraction (HFrEF), evaluating the effect of dapagliflozin versus placebo, given once daily in addition to background regional standard of care therapy, for the prevention of cardiovascular (CV) death or reduction of heart failure (HF) events.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 4744 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure With Reduced Ejection Fraction
Actual Study Start Date : February 8, 2017
Actual Primary Completion Date : July 17, 2019
Actual Study Completion Date : July 17, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Arm Intervention/treatment
Experimental: Dapagliflozin
Patients will be randomized 1:1 to either dapagliflozin or placebo.
Drug: Dapagliflozin
10 mg or 5 mg tablets given once daily, per oral use.
Other Names:
  • Forxiga TM
  • Farxiga TM

Placebo Comparator: Placebo
Placebo matching dapagliflozin.
Drug: Placebo
Placebo matching dapagliflozin 10 mg or 5 mg.




Primary Outcome Measures :
  1. Time to the first occurrence of any of the components of the composite: CV death or hospitalization for HF or an urgent HF visit. [ Time Frame: From randomization visit (day 0) up to approximately 3 years ]

Secondary Outcome Measures :
  1. Time to the first occurrence of either of the components of the composite: CV death or hospitalization for HF. [ Time Frame: From randomization visit (day 0) up to approximately 3 years ]
  2. Total number of (first and recurrent) HF hospitalizations and CV death. [ Time Frame: From randomization visit (day 0) up to approximately 3 years ]
  3. Change from baseline measured at 8 months in the total symptom score of the Kansas City Cardiomyopathy Questionnaire (KCCQ), a specific HF patient reported outcome questionnaire. [ Time Frame: From randomization visit (day 0) up to 8 months (day 240) ]
  4. Time to the first occurrence of any of the components of the composite: ≥50% sustained decline in eGFR or reaching End Stage Renal Disease (ESRD) or renal death. [ Time Frame: From randomization visit (day 0) up to approximately 3 years ]

    End Stage Renal Disease (ESRD) is defined as;

    • Sustained eGFR <15 mL/min/1.73m^2 or,
    • Chronic dialysis treatment or,
    • Receiving a renal transplant

  5. Time to death from any cause. [ Time Frame: From randomization visit (day 0) up to approximately 3 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 130 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Provision of signed informed consent prior to any study specific procedures
  • Male or female, aged ≥18 years
  • Established documented diagnosis of symptomatic HFrEF (NYHA functional class II-IV), which has been present for at least 2 months
  • LVEF≤40%
  • Elevated NT-proBNP levels
  • Patients should receive background standard of care for HFrEF and be treated according to locally recognized guidelines
  • eGFR ≥30 mL/min/1.73 m^2 (CKD-EPI formula) at enrolment (visit 1)

Exclusion Criteria:

  • Receiving therapy with an SGLT2 inhibitor within 8 weeks prior to enrolment or previous intolerance of an SGLT2 inhibitor
  • Type 1 diabetes mellitus
  • Symptomatic hypotension or systolic BP <95 mmHg at 2 out of 3 measurements either at visit 1 or visit 2
  • Current acute decompensated HF or hospitalization due to decompensated HF <4 weeks prior to enrolment
  • MI, unstable angina, stroke or transient ischemic attack within 12 weeks prior to enrolment
  • Coronary revascularization (percutaneous coronary intervention or coronary artery bypass grafting) or valvular repair/replacement within 12 weeks prior to enrolment or planned to undergo any of these operations after randomization
  • Implantation of a CRT within 12 weeks prior to enrolment or intent to implant a CRT device
  • Previous cardiac transplantation or implantation of a ventricular assistance device or similar device, or implantation expected after randomization
  • HF due to restrictive cardiomyopathy, active myocarditis, constrictive pericarditis, hypertrophic (obstructive) cardiomyopathy or uncorrected primary valvular disease
  • Symptomatic bradycardia or second or third degree heart block without a pacemaker
  • Severe (eGFR <30 mL/min/1.73 m^2 by CKD-EPI), unstable or rapidly progressing renal disease at the time of randomization

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03036124


  Hide Study Locations
Locations
Layout table for location information
United States, Alabama
Research Site
Alexander City, Alabama, United States, 35010
Research Site
Fairhope, Alabama, United States, 36532
Research Site
Mobile, Alabama, United States, 36608
Research Site
Sheffield, Alabama, United States, 35660
United States, California
Research Site
Bakersfield, California, United States, 93309
Research Site
Beverly Hills, California, United States, 90211
Research Site
Los Angeles, California, United States, 90073
Research Site
Palm Springs, California, United States, 92262
Research Site
Stockton, California, United States, 95204
Research Site
Torrance, California, United States, 90502
Research Site
Vista, California, United States, 92083
United States, Delaware
Research Site
Wilmington, Delaware, United States, 19803
United States, Florida
Research Site
Boynton Beach, Florida, United States, 33472
Research Site
Jacksonville, Florida, United States, 32209
Research Site
Jacksonville, Florida, United States, 32216
Research Site
Lake Worth, Florida, United States, 33461
Research Site
Miami, Florida, United States, 33125
Research Site
Miami, Florida, United States, 33155
Research Site
Naples, Florida, United States, 34102
Research Site
New Smyrna Beach, Florida, United States, 32169
Research Site
Pembroke Pines, Florida, United States, 33024
Research Site
Port Charlotte, Florida, United States, 33952
Research Site
Saint Augustine, Florida, United States, 32086
Research Site
Wellington, Florida, United States, 33449
United States, Georgia
Research Site
Atlanta, Georgia, United States, 30303
Research Site
Cumming, Georgia, United States, 30041
Research Site
Tucker, Georgia, United States, 30084
United States, Illinois
Research Site
Hazel Crest, Illinois, United States, 60429
Research Site
Jerseyville, Illinois, United States, 62052
Research Site
Peoria, Illinois, United States, 61614
United States, Kentucky
Research Site
Louisville, Kentucky, United States, 40205
United States, Louisiana
Research Site
Alexandria, Louisiana, United States, 71301
Research Site
Chalmette, Louisiana, United States, 70043
United States, Maine
Research Site
Bangor, Maine, United States, 04401
United States, Maryland
Research Site
Baltimore, Maryland, United States, 21228
Research Site
Baltimore, Maryland, United States, 21229
Research Site
Columbia, Maryland, United States, 21044
United States, Massachusetts
Research Site
Boston, Massachusetts, United States, 02114
Research Site
Haverhill, Massachusetts, United States, 01830
United States, Michigan
Research Site
Flint, Michigan, United States, 48504
Research Site
Flint, Michigan, United States, 48532
Research Site
Lansing, Michigan, United States, 48910
United States, Minnesota
Research Site
Minneapolis, Minnesota, United States, 55407
Research Site
Minneapolis, Minnesota, United States, 55417
United States, Mississippi
Research Site
Tupelo, Mississippi, United States, 38801
United States, Missouri
Research Site
Kansas City, Missouri, United States, 64111
Research Site
Saint Louis, Missouri, United States, 63128
United States, Montana
Research Site
Great Falls, Montana, United States, 59405
United States, Nebraska
Research Site
Grand Island, Nebraska, United States, 68803
Research Site
Lincoln, Nebraska, United States, 68526
Research Site
Omaha, Nebraska, United States, 68105
United States, Nevada
Research Site
Las Vegas, Nevada, United States, 89128
United States, New Jersey
Research Site
Bridgewater, New Jersey, United States, 08807
Research Site
New Brunswick, New Jersey, United States, 08901
Research Site
Somerset, New Jersey, United States, 08873
United States, New York
Research Site
Bronx, New York, United States, 10459
Research Site
Buffalo, New York, United States, 14203
Research Site
Buffalo, New York, United States, 14215
Research Site
Cortlandt Manor, New York, United States, 10567
Research Site
New York, New York, United States, 10001
Research Site
Orchard Park, New York, United States, 14127
Research Site
Poughkeepsie, New York, United States, 12601
Research Site
Rosedale, New York, United States, 11422
United States, North Carolina
Research Site
Burlington, North Carolina, United States, 27215
United States, Ohio
Research Site
Cleveland, Ohio, United States, 44106-6010
Research Site
Columbus, Ohio, United States, 43210
United States, Pennsylvania
Research Site
Altoona, Pennsylvania, United States, 16602
Research Site
Philadelphia, Pennsylvania, United States, 19104
Research Site
Pittsburgh, Pennsylvania, United States, 15212
Research Site
Pittsburgh, Pennsylvania, United States, 15240
United States, South Dakota
Research Site
Rapid City, South Dakota, United States, 57701
United States, Tennessee
Research Site
Knoxville, Tennessee, United States, 37912
Research Site
Memphis, Tennessee, United States, 38104
Research Site
Nashville, Tennessee, United States, 37212
Research Site
Tullahoma, Tennessee, United States, 37388
United States, Texas
Research Site
Beaumont, Texas, United States, 77702
Research Site
Dallas, Texas, United States, 75231
Research Site
Dallas, Texas, United States, 75246
Research Site
Fort Sam Houston, Texas, United States, 78234
Research Site
Houston, Texas, United States, 77002
Research Site
Kingwood, Texas, United States, 77339
Research Site
Tyler, Texas, United States, 75701
United States, Utah
Research Site
Farmington, Utah, United States, 84025
United States, Virginia
Research Site
Falls Church, Virginia, United States, 22042
Research Site
Richmond, Virginia, United States, 23298
United States, Washington
Research Site
Seattle, Washington, United States, 98101
Research Site
Seattle, Washington, United States, 98195
Argentina
Research Site
Buenos Aires, Argentina, C1180AAX
Research Site
Buenos Aires, Argentina, C1425AGC
Research Site
Caba, Argentina, 1428
Research Site
Caba, Argentina, 1437
Research Site
Caba, Argentina, C1119ACN
Research Site
Caba, Argentina, C1120AAC
Research Site
Ciudad Autonoma Buenos Aires, Argentina, 1093
Research Site
Ciudad Autonoma de Buenos Aire, Argentina, C1440CFD
Research Site
Ciudad de Buenos Aires, Argentina, 1221
Research Site
Cordoba, Argentina, 5003
Research Site
Cordoba, Argentina, X5006CBI
Research Site
Corrientes, Argentina, 3400
Research Site
Córdoba, Argentina, X5004BAL
Research Site
Esperanza, Argentina, S3080BQU
Research Site
Mar del Plata, Argentina, 7600
Research Site
Mar del Plata, Argentina, B7600FZN
Research Site
Quilmes, Argentina, B1878DVB
Research Site
Quilmes, Argentina, B1878GEG
Research Site
Ramos Mejía, Argentina, B1704ETD
Research Site
Rosario, Argentina, 2000
Research Site
Rosario, Argentina, S2000CVD
Research Site
San Luis, Argentina, 5700
Research Site
San Martin, Argentina, 1650
Research Site
San Miguel de Tucuman, Argentina, 4000
Research Site
San Nicolás, Argentina, B2900DMH
Research Site
Santa Fe, Argentina, S3000FWO
Research Site
Vicente Lopez, Argentina, 1638
Brazil
Research Site
Belo Horizonte, Brazil, 30140 062
Research Site
Belo Horizonte, Brazil, 30150-240
Research Site
Brasilia, Brazil, 71625-175
Research Site
Brasillia, Brazil, 70200-730
Research Site
Campina Grande do Sul, Brazil, 83430000
Research Site
Campinas, Brazil, 13060-080
Research Site
Curitiba, Brazil, 80730-150
Research Site
Goiânia, Brazil, 74605050
Research Site
Marilia, Brazil, 17515-000
Research Site
Porto Alegre, Brazil, 90020-090
Research Site
Porto Alegre, Brazil, 90035-903
Research Site
Porto Alegre, Brazil, 90620-001
Research Site
Porto Alegre, Brazil, 90840-440
Research Site
Porto Alegre, Brazil, 91350-200
Research Site
Rio de Janeiro, Brazil, 22271-100
Research Site
Sao Paulo, Brazil, 05403-000
Research Site
São José do Rio Preto, Brazil, 15090-000
Research Site
Uberlandia, Brazil, 38411-186
Research Site
Votuporanga, Brazil, 15500-003
Bulgaria
Research Site
Blagoevgrad, Bulgaria, 2700
Research Site
Dimitrovgrad, Bulgaria, 6400
Research Site
Haskovo, Bulgaria
Research Site
Kyustendil, Bulgaria, 2500
Research Site
Lom, Bulgaria, 3600
Research Site
Pleven, Bulgaria, 5800
Research Site
Plovdiv, Bulgaria, 4000
Research Site
Plovdiv, Bulgaria, 4001
Research Site
Plovdiv, Bulgaria, 4002
Research Site
Plovdiv, Bulgaria, 4003
Research Site
Sofia, Bulgaria, 1309
Research Site
Sofia, Bulgaria, 1408
Research Site
Sofia, Bulgaria, 1431
Research Site
Sofia, Bulgaria, 1463
Research Site
Sofia, Bulgaria, 1527
Research Site
Sofia, Bulgaria, 1606
Research Site
Sofia, Bulgaria, 1750
Canada, Alberta
Research Site
Calgary, Alberta, Canada, T2N 4Z6
Canada, British Columbia
Research Site
Abbotsford, British Columbia, Canada, V2S 3N2
Research Site
New Westminster, British Columbia, Canada, V3L 3W4
Research Site
North Vancouver, British Columbia, Canada, V7M 2H4
Canada, New Brunswick
Research Site
Moncton, New Brunswick, Canada, E1C 2Z3
Research Site
Saint John, New Brunswick, Canada, E2L 4L2
Canada, Ontario
Research Site
Brampton, Ontario, Canada, L6W 2X7
Research Site
Cambridge, Ontario, Canada, N1R 6V6
Research Site
Cambridge, Ontario, Canada, N1R 7R1
Research Site
Hamilton, Ontario, Canada, L8L 2X2
Research Site
London, Ontario, Canada, N6A 5A5
Research Site
Newmarket, Ontario, Canada, L3Y 2P6
Research Site
North York, Ontario, Canada, M6B 3H7
Research Site
Oakville, Ontario, Canada, L6K 3W7
Research Site
Oshawa, Ontario, Canada, L1J 2K1
Research Site
Peterborough, Ontario, Canada, K9J 0B2
Research Site
Port Perry, Ontario, Canada, L9L 1L1
Research Site
Scarborough, Ontario, Canada, M1B 4Z8
Research Site
Scarborough, Ontario, Canada, M1E 5E9
Research Site
Waterloo, Ontario, Canada, N2T 0C1
Research Site
York, Ontario, Canada, M9N 1W4
Canada, Quebec
Research Site
Greenfield Park, Quebec, Canada, J4V 2G8
Research Site
Montreal, Quebec, Canada, H1T 1C8
Research Site
Montreal, Quebec, Canada, H1T 3Y7
Research Site
Montreal, Quebec, Canada, H2X 0A9
Research Site
Rimouski, Quebec, Canada, G5L 5T1
Research Site
Saint-Jerome, Quebec, Canada, J7Z 5T3
Research Site
Terrebonne, Quebec, Canada, J6V 2H2
Canada
Research Site
Quebec, Canada, G1V 4G5
China
Research Site
Baotou, China, 014010
Research Site
Beijing, China, 100029
Research Site
Beijing, China
Research Site
Bengbu, China, 233060
Research Site
Changchun, China, 130021
Research Site
Changsha, China, 410011
Research Site
Chifeng, China, 024000
Research Site
Dalian, China, 116011
Research Site
Guangzhou, China, 510080
Research Site
Haerbin, China, 150001
Research Site
Lanzhou, China, 730030
Research Site
Nanchang, China, 330006
Research Site
Nanjing, China, 210009
Research Site
Nanjing, China, 210029
Research Site
Ningbo, China, 315010
Research Site
Pingxiang, China, 337055
Research Site
Shanghai, China, 200025
Research Site
Shanghai, China, 200032
Research Site
Shanghai, China, 200062
Research Site
Shanghai, China, 200090
Research Site
Shanghai, China, 200120
Research Site
Shenyang, China, 110001
Research Site
Shenzhen, China, 518036
Research Site
Tianjin, China, 300211
Research Site
Wuhan, China, 430033
Research Site
Wuhan, China, 430060
Research Site
Xuzhou, China, 221006
Research Site
Xuzhou, China, 221009
Research Site
Yinchuan, China, 750004
Research Site
Zhuhai, China, 519000
Czechia
Research Site
Benesov, Czechia, 256 01
Research Site
Brno, Czechia, 62500
Research Site
Brno, Czechia, 656 91
Research Site
Kolin, Czechia, 280 00
Research Site
Louny, Czechia, 440 01
Research Site
Ostrava-Dubina, Czechia, 700 30
Research Site
Plzen, Czechia, 320 00
Research Site
Praha 2, Czechia, 12808
Research Site
Praha 4, Czechia, 140 00
Research Site
Praha 5, Czechia, 150 00
Research Site
Praha, Czechia, 140 59
Research Site
Trebic, Czechia, 674 01
Denmark
Research Site
Hellerup, Denmark, 2900
Research Site
Herlev, Denmark, 2730
Research Site
Hvidovre, Denmark, 2650
Research Site
København Ø, Denmark, 2100
Research Site
Odense C, Denmark, 5000
Research Site
Svendborg, Denmark, DK-5700
Germany
Research Site
Bad Oeynhausen, Germany, 32545
Research Site
Berlin, Germany, 13347
Research Site
Berlin, Germany, 13597
Research Site
Dresden, Germany, 01099
Research Site
Dresden, Germany, 01307
Research Site
Hamburg, Germany, 22041
Research Site
Homburg, Germany, 66424
Research Site
Kassel, Germany, 34121
Research Site
Leipzig, Germany, 04107
Research Site
Mainz, Germany, 55131
Research Site
Papenburg, Germany, 26871
Research Site
Stuttgart, Germany, 70199
Research Site
Wermsdorf, Germany, 04779
Hungary
Research Site
Budapest, Hungary, 1115
Research Site
Budapest, Hungary, 1122
Research Site
Budapest, Hungary, 1135
Research Site
Budapest, Hungary, 1139
Research Site
Budapest, Hungary, H-1106
Research Site
Kecskemét, Hungary, 6000
Research Site
Mosonmagyaróvár, Hungary, 9200
Research Site
Szentes, Hungary, 6600
Research Site
Székesfehérvár, Hungary, 8000
Research Site
Zalaegerszeg, Hungary, 8900
India
Research Site
Ahmedabad, India, 380060
Research Site
Aurangabad, India, 431003
Research Site
Bangalore, India, 560074
Research Site
Belagavi, India, 590010
Research Site
Ernakulam, India, 683594
Research Site
Gurgaon, India, 122001
Research Site
Kanpur, India, 208002
Research Site
Karamsad, India, 388345
Research Site
Kolkata, India, 700020
Research Site
Maharashtra, India, 411013
Research Site
Nadiad, India, 387002
Research Site
Nagpur, India, 420012
Research Site
Nagpur, India, 440003
Research Site
New Delhi, India, 110002
Research Site
Pune, India, 411001
Research Site
Pune, India, 411011
Japan
Research Site
Adachi-ku, Japan, 123-0845
Research Site
Aki-gun,, Japan, 735-8585
Research Site
Azumino-shi, Japan, 399-8292
Research Site
Beppu-shi, Japan, 874-0011
Research Site
Bunkyo-ku, Japan, 113-8431
Research Site
Chikushino-shi, Japan, 818-8516
Research Site
Chuo-ku, Japan, 103-0027
Research Site
Chuo-ku, Japan, 104-8560
Research Site
Fujisawa-shi, Japan, 251-0041
Research Site
Fujisawa-shi, Japan, 251-8550
Research Site
Fukuoka-shi, Japan, 815-8555
Research Site
Hachioji-shi, Japan, 192-0918
Research Site
Hamamatsu-shi, Japan, 430-0929
Research Site
Himeji-shi, Japan, 670-0981
Research Site
Hiratsuka-shi, Japan, 254-8502
Research Site
Hitachinaka-shi, Japan, 312-0057
Research Site
Iizuka-shi, Japan, 820-8505
Research Site
Itabashi-ku, Japan, 173-8610
Research Site
Iwakuni-shi, Japan, 740-8510
Research Site
Kagoshima-shi, Japan, 890-8520
Research Site
Kakamigahara-shi, Japan, 504-8601
Research Site
Kasama-shi, Japan, 309-1793
Research Site
Kishiwada-shi, Japan, 596-8522
Research Site
Kitakyusyu-shi, Japan, 806-8501
Research Site
Kumamoto-shi, Japan, 860-0008
Research Site
Kure-shi, Japan, 737-0023
Research Site
Kusatsu-shi, Japan, 525-8585
Research Site
Kyoto-shi, Japan, 601-1434
Research Site
Matsudo-shi, Japan, 270-2251
Research Site
Matsudo-shi, Japan, 271-0077
Research Site
Matsumoto-shi, Japan, 390-8621
Research Site
Matsuyama-shi, Japan, 790-0067
Research Site
Meguro-ku, Japan, 152-8902
Research Site
Mito-shi, Japan, 311-4198
Research Site
Miura-gun, Japan, 240-0116
Research Site
Nagasaki-shi, Japan, 850-8555
Research Site
Nagoya-shi, Japan, 453-8511
Research Site
Nagoya-shi, Japan, 455-8530
Research Site
Nagoya-shi, Japan, 457-8511
Research Site
Nagoya-shi, Japan, 460-0001
Research Site
Nishinomiya-shi, Japan, 663-8501
Research Site
Okayama-shi, Japan, 700-0804
Research Site
Osaka-shi, Japan, 530-0001
Research Site
Osaka-shi, Japan, 540-0006
Research Site
Sagamihara-shi, Japan, 252-5188
Research Site
Sakai-shi,Kita-ku, Japan, 591-8025
Research Site
Sakaide-shi, Japan, 762-0007
Research Site
Sanyoonoda-shi, Japan, 756-0095
Research Site
Sayama-shi, Japan, 350-1305
Research Site
Sendai-shi, Japan, 980-0803
Research Site
Sendai-shi, Japan, 983-0045
Research Site
Shimonoseki-shi, Japan, 750-0061
Research Site
Shinjuku-ku, Japan, 169-0073
Research Site
Suita-shi, Japan, 564-8565
Research Site
Suwa-shi, Japan, 392-8510
Research Site
Tachikawa-shi, Japan, 190-8531
Research Site
Takamatsu-shi, Japan, 760-0018
Research Site
Takasaki-shi, Japan, 370-0829
Research Site
Toride-shi, Japan, 302-0022
Research Site
Tsuchiura-shi, Japan, 300-0028
Research Site
Tsukuba-shi, Japan, 305-0005
Research Site
Ueda-shi, Japan, 386-8610
Research Site
Wakayama-shi, Japan, 640-8505
Research Site
Wakayama-shi, Japan, 649-6335
Research Site
Wako-shi, Japan, 351-0102
Research Site
Yokohama-shi, Japan, 236-0051
Netherlands
Research Site
Apeldoorn, Netherlands, 7334 DZ
Research Site
Den Bosch, Netherlands, 5223 GZ
Research Site
Den Haag, Netherlands, 2545 AA
Research Site
Gouda, Netherlands, 2803 HH
Research Site
Groningen, Netherlands, 9713 GZ
Research Site
Nijmegen, Netherlands, 6525 GA
Research Site
Rotterdam, Netherlands, 3045 PM
Research Site
Rotterdam, Netherlands, 3083 AN
Research Site
Sneek, Netherlands, 8601 ZR
Research Site
Veldhoven, Netherlands, 5504 DB
Poland
Research Site
Bochnia, Poland, 32-700
Research Site
Gdynia, Poland, 81-423
Research Site
Jasło, Poland, 38-200
Research Site
Katowice, Poland, 40-081
Research Site
Kraków, Poland, 30-082
Research Site
Kędzierzyn Koźle, Poland, 47-200
Research Site
Legnica, Poland, 59-220
Research Site
Lublin, Poland, 20-044
Research Site
Oława, Poland, 55-200
Research Site
Płock, Poland, 09-402
Research Site
Sokółka, Poland, 16-100
Research Site
Torun, Poland, 87-100
Research Site
Wierzchosławice, Poland, 33-122
Research Site
Łódź, Poland, 92-213
Russian Federation
Research Site
Ekaterinburg, Russian Federation, 620039
Research Site
Gatchina, Russian Federation, 188300
Research Site
Izhevsk, Russian Federation, 426063
Research Site
Kazan, Russian Federation, 420012
Research Site
Moscow, Russian Federation, 109263
Research Site
Moscow, Russian Federation, 119435
Research Site
Moscow, Russian Federation, 121551
Research Site
Moscow, Russian Federation, 121552
Research Site
Novosibirsk, Russian Federation, 630055
Research Site
Perm, Russian Federation, 6144090
Research Site
Ryazan, Russian Federation, 390039
Research Site
Saint Petersburg, Russian Federation, 196601
Research Site
Saint Petersburg, Russian Federation, 198260
Research Site
Saint-Petersburg, Russian Federation, 192283
Research Site
Saint-Petersburg, Russian Federation, 194291
Research Site
Saint-Petersburg, Russian Federation, 194354
Research Site
Saint-Petersburg, Russian Federation, 195067
Research Site
St. Petersburg, Russian Federation, 196084
Research Site
Tver, Russian Federation, 170036
Research Site
Yekaterinburg, Russian Federation, 620102
Slovakia
Research Site
Brezno, Slovakia, 97742
Research Site
Kosice, Slovakia, 040 01
Research Site
Lucenec, Slovakia, 984 01
Research Site
Martin, Slovakia, 036 01
Research Site
Nove Zamky, Slovakia, 94001
Research Site
Presov, Slovakia, 080 01
Research Site
Svidnik, Slovakia, 08901
Research Site
Trebisov, Slovakia, 075 01
Research Site
Trnava, Slovakia, 917 01
Research Site
Zilina, Slovakia, 010 01
Sweden
Research Site
Göteborg, Sweden, 413 45
Research Site
Lund, Sweden, 222 21
Research Site
Ostersund, Sweden, 831 83
Research Site
Stockholm, Sweden, 118 83
Research Site
Umeå, Sweden, 90737
Taiwan
Research Site
Changhua City, Taiwan, 50006
Research Site
Hsinchu, Taiwan, 300
Research Site
Kaohsiung, Taiwan, 80756
Research Site
Kaohsiung, Taiwan
Research Site
Kweishan Shiang, Taiwan, 333
Research Site
Taichung, Taiwan, 40705
Research Site
Taichung, Taiwan
Research Site
Tainan, Taiwan, 70403
Research Site
Tainan, Taiwan, 710
Research Site
Taipei, Taiwan, 11217
Research Site
Taipei, Taiwan, 11220
Research Site
Taipei, Taiwan
United Kingdom
Research Site
Airdrie, United Kingdom, ML6 0JS
Research Site
Clydebank, United Kingdom, G81 4DY
Research Site
Cottingham, United Kingdom, HU16 5JQ
Research Site
Dundee, United Kingdom, DD1 9SY
Research Site
Edinburgh, United Kingdom, EH16 4SA
Research Site
Glasgow, United Kingdom, G31 2ER
Research Site
Glasgow, United Kingdom, G51 4TF
Research Site
Inverness, United Kingdom, IV2 3JH
Research Site
Nottingham, United Kingdom, NG5 1PB
Research Site
Paisley, United Kingdom, PA2 9PN
Vietnam
Research Site
Hanoi, Vietnam
Research Site
Hcmc, Vietnam
Research Site
Ho Chi Minh, Vietnam, 700000
Research Site
Ho Chi Minh, Vietnam
Sponsors and Collaborators
AstraZeneca

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: AstraZeneca
ClinicalTrials.gov Identifier: NCT03036124     History of Changes
Other Study ID Numbers: D1699C00001
2016-003897-41 ( EudraCT Number )
First Posted: January 30, 2017    Key Record Dates
Last Update Posted: August 15, 2019
Last Verified: August 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: Yes
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by AstraZeneca:
HFrEF
Heart Failure (HF)
Cardiovascular Events (CV)
Phase III outcome trial
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
Sodium-Glucose Transporter 2 Inhibitors
Molecular Mechanisms of Pharmacological Action
Hypoglycemic Agents
Physiological Effects of Drugs